← Back to Influence Map
Pharmaceutical Research and Manufacturers of America (PhRMA)
OrganizationThe largest and most influential pharmaceutical trade association in the US. Spends over $30 million per year on lobbying, making it one of the top lobbying organizations in Washington. Led opposition to Medicare drug price negotiation.
pharmaceuticals
Given
$0
Received
$11,248
Connections
11
Votes
0
Donations Received
| Donor | Amount | Date | Cycle |
|---|---|---|---|
| Merck & Co. Inc. PAC | $5,000 | Sep 15, 2024 | |
| Pfizer Inc. PAC | $5,000 | Nov 22, 2024 | |
| NIKKI FOR CONGRESS | $1,248 | Aug 7, 2024 |
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | TIBER CREEK HEALTH STRATEGIES, INC. | Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on Pharmaceuticals | Source |
| Employed by | DESIMONE CONSULTING, LLC | Hired DESIMONE CONSULTING, LLC to lobby on Pharmaceuticals | Source |
| Employed by | ADVANCED POLICY CONSULTING, LLC | Hired ADVANCED POLICY CONSULTING, LLC to lobby on Pharmaceuticals | Source |
| Funded research at | The Heritage Foundation | PhRMA funds Heritage health policy research | |
| Funded research at | American Enterprise Institute | PhRMA funds AEI pharmaceutical regulation research | |
| Funded research at | The Brookings Institution | PhRMA funds Brookings health policy research | |
| Instrument of | Pharmaceutical industry | PhRMA is the flagship lobbying organization for brand-name drug manufacturers | |
| Advocated for | Medicare Drug Price Negotiation - First 10 Drugs Selected | PhRMA and member companies filed lawsuits challenging Medicare drug price negotiation | |
| Advocated for | MARCH-IN Rights Proposal (NIH Framework) | PhRMA led industry opposition to the march-in rights framework | |
| Instrument of (target) | PhRMA PAC | PhRMA PAC is the political arm of the PhRMA trade association | |
| Worked for (target) | Stephen Ubl | President and CEO of PhRMA since 2015 |